Table 3

Mean Changes in CQM Outcomes From Baseline (2015) to Follow-up (2017)

CQM OutcomeaAdjustedb Change,c Mean (95% CI)Adjustedb Difference in Mean Change vs PF Only, Mean Difference (95% CI)Overall P Valued
PF OnlyPF + SLPF + EOVPF + EOV + SLPF + SLPF + EOVPF + EOV + SL
Blood pressure2.46 (−2.03 to 6.95)4.80 (0.08 to 9.53)2.78 (−0.67 to 6.23)4.84 (2.53 to 7.16)2.34 (−4.71 to 9.39)0.32 (−6.59 to 7.22)2.38 (−2.31 to 7.08).40
Aspirin2.28 (−3.02 to 7.57)4.02 (1.25 to 6.78)3.49 (0.24 to 6.74)5.54 (−0.16 to 11.25)1.74 (−4.82 to 8.30)1.21 (−4.74 to 7.16)3.26 (−6.05 to 12.58).90
Smoking9.41 (3.27 to 15.55)7.52 (0.07 to 14.96)6.25 (0.37 to 12.12)5.87 (−0.05 to 11.79)−1.90 (−11.64 to 7.85)−3.17 (−12.83 to 6.50)−3.54 (−11.69 to 4.61).80
  • CQM = clinical quality measure; CVD = cardiovascular disease; EOV = educational outreach visit; PF = practice facilitation; SL = shared learning.

  • a CQM outcomes are defined as the percent of eligible target population (denominator) meeting the clinical quality standard (numerator) for each CVD quality measure.

  • b Models adjusted for site, prior experience obtaining customized data, prioritization of quality improvement work, and the 2015 measure of the CQM outcome.

  • c Positive value for change indicates an increase (improvement) in the mean percent of the practices’ target population meeting the CQM; negative value for change indicates a decrease.

  • d Overall P value is a global test for whether the mean change in CQM outcome in any of the study arms receiving enhanced services (PF + SL, PF + EOV, or PF + EOV + SL) differs when compared with that in the PF-only group.